41 of 500
Johnson & Johnson
Johnson & Johnson
41
Financials: Latest Results
Rank: 41
Previous rank: 42
CEO: Alex Gorsky

After a rough few years for the multibillion-dollar pharmaceutical company --including recalls, lawsuits and a bruising management shakeup -- Johnson & Johnson regained some momentum last year. The sprawling conglomerate still makes everything from baby powder to artificial hips. But most of J&J's recent growth has been fueled by its pharmaceutical division, which makes the blockbuster drugs Remicade, for Crohn's Disease and rheumatoid arthritis, and Stelara, immunology medication.

Headquarters:
1 Johnson & Johnson Plaza
New Brunswick, NJ. 08933
732-524-0400
Website: www.jnj.com
Network with Johnson & Johnson
Key financials
$ millions
% change from 2011
Revenues
67,224
3.4
Profits
10,853
12.2
Assets
121,347
Stockholder's equity
64,826
Market cap (on 3/29/2013)
227,902.4
Profits as % of
Revenues
16.1
Assets
8.9
Stockholders' equity
16.7
Earnings per share
2012$
3.86
% change from 2011
10.6
2002-2012 annual growth rate %
6
Total return to investors
%
2012
10.8
2002-2012 annual rate
5.5
From the May 20, 2013 issue


What do you think of Johnson & Johnson?
Companies are ranked by total revenues for their respective fiscal years. Included in the survey are companies that are incorporated in the U.S. and operate in the U.S. and file financial statements with a government agency. More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.